Clinical Trials in Baltimore

Showing 10381-10400 of 23,476 trials

Intra-operative Uterosacral Ligament Bupivacaine Injection During Minimally Invasive Hysterectomy

NCT04157075

This is proof of concept, phase I randomized controlled trial studying a short acting non-opioid anesthetic, bupivacaine to improve post-operative pain in gynecologic surgery patients. Patients who are undergoing minimally invasive (laparoscopic or robotic) hysterectomy will be randomized to receive no uterosacral injection, normal saline uterosacral injection, or 0.25% bupivacaine uterosacral injection just prior to colpotomy (incision around the cervix and removal of uterus) during minimally invasive hysterectomy.

Pain, PostoperativeOpioid Use

Johns Hopkins University180 participantsStarted Mar 2021

Baltimore, Maryland, United States • Columbia, Maryland, United States

COMPLETEDPhase 3< 1 mile

RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial

NCT00358215

The purpose of the study is to determine the efficacy of treatment of anemia with darbepoetin alfa compared to placebo on the composite of time to death from any cause or first hospital admission for worsening heart failure in patients with symptomatic left ventricular systolic dysfunction and anemia.

Heart FailureAnemiaCardiovascular Disease+2 more

Amgen2,278 participantsStarted Jun 2006

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +751 more locations

Intra-operative Uterosacral Ligament Bupivacaine Injection During Minimally Invasive Hysterectomy

RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial

Find Trials by Condition in Baltimore

LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2

Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies

Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Adult Participants

Brain-Computer Interface Implant for Severe Communication Disability

A Study to Investigate CSL312 in Subjects With Hereditary Angioedema (HAE)

Vascular Inflammation in Psoriasis - Apremilast

Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels

A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients

Self-control and Body-focused Repetitive Behaviors

Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease

Clinical Performance of Two Commercial, Daily Disposable Contact Lenses

Long-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Pain

Collection and Distribution of Biospecimens for Novel Research

Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer

A Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease

Sotrovimab Expanded Access Treatment Protocol (COVID-19)

Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer

Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2